We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

このNeurology Advisorについて

神経Advisorは、複数のソースから最高の神経情報を集約

Neurology Advisor is a free, simple to use, medical app that offers neurologic healthcare professionals a comprehensive knowledge base of practical neurology information and resources to assist in making the right decisions for their patients. It provides daily news, full-length features, medical slideshows, case studies, opinion articles written by experts in the field, concise drug monographs and continuing medical education (CME) activities.

The Neurology Advisor app aggregates the best neurology information from several partners including free CME/CE courses from myCME.com and drug information from eMPR.com, plus all of the content from our website.

With the Neurology Advisor app, you get access to:

• Concise drug monographs

• Daily news

• Full-length feature articles

• Unique neurology case studies

• Conference coverage

• Relevant clinical charts

• Continuing medical education (CME) activities

Our mission is to offer the most recent clinical research news and evidence-based guidance that will aid health care professionals in the management of neurologic conditions.

Haymarket Media offers a wide range of authoritative publications and services for the professional medical community including Monthly Prescribing Reference (MPR), Clinical Advisor, for nurse practitioners and physician assistants, Chemotherapy Advisor, Oncology Nurse Advisor and Renal and Urology News.

最新バージョン 2.3.1.295 の更新情報

Last updated on 2018年02月16日

Minor bug fixes and improvements

翻訳中...

アプリの追加情報

最終のバージョン

Neurology Advisor 更新を申請する 2.3.1.295

投稿者

Nattaphum Nonta

Android 要件

Android 4.4+

もっと見る

Neurology Advisor スクリーンショット

言語
APKPureをを購読する
最高のAndroidゲームアプリの最新リリースやニュースやガイドなどの情報にいち早くアクセスすることができます。
いいえ結構です
購読
購読完了!
APKPureの購読が完了しました。
APKPureをを購読する
最高のAndroidゲームアプリの最新リリースやニュースやガイドなどの情報にいち早くアクセスすることができます。
いいえ結構です
購読
成功!
ニュースレターを購読しました。